SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-12-05 17:47
Tx date 2025-12-05 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-75,400
-10,000 vol
$7.54 each 		2,688,343
Filed 2025-12-03 16:43
Tx date 2025-12-01 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+5,208 vol 		2,698,343
Filed 2025-12-03 16:40
Tx date 2025-12-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,430 vol 		230,450
Filed 2025-11-18 12:12
Tx date 2025-11-17 		$FRX
Fennec Pharmaceuticals Inc. 		Southpoint Capital Advisors LP
3 - 10% Security Holder of Issuer
Holder: Southpoint Master Fund LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-755,193.4446
-85,918 vol
$8.79 each 		3,764,082
Filed 2025-11-18 12:11
Tx date 2025-11-14 		$FRX
Fennec Pharmaceuticals Inc. 		Southpoint Capital Advisors LP
3 - 10% Security Holder of Issuer
Holder: Southpoint Master Fund LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,280,431.77
-160,100 vol
$8.00 each 		3,850,000
Filed 2025-11-06 17:58
Tx date 2025-11-05 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-81,000
-10,000 vol
$8.10 each 		2,693,135
Filed 2025-11-06 17:57
Tx date 2025-11-03 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+5,208 vol 		2,703,135
Filed 2025-11-06 17:55
Tx date 2025-11-03 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,430 vol 		228,020
Filed 2025-10-10 13:22
Tx date 2025-10-10 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-16,401
-1,775 vol
$9.24 each 		55,316
Filed 2025-10-10 13:21
Tx date 2025-10-10 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,996
+4,062 vol
$1.23 each 		57,091
Filed 2025-10-10 13:20
Tx date 2025-10-10 		$FRX
Fennec Pharmaceuticals Inc. 		Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-4,996.26
-4,062 vol
$1.23 each 		226,573
Filed 2025-10-10 13:13
Tx date 2025-10-08 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$11,292
+4,609 vol
$2.45 each 		2,697,927
Filed 2025-10-10 13:12
Tx date 2025-10-08 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-11,292.05
-4,609 vol
$2.45 each 		21,482,847
Filed 2025-10-10 12:10
Tx date 2025-10-09 		$FRX
Fennec Pharmaceuticals Inc. 		Southpoint Capital Advisors LP
3 - 10% Security Holder of Issuer
Holder: Southpoint Master Fund LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-192,613.7749
-20,609 vol
$9.35 each 		4,010,100
Filed 2025-10-10 12:09
Tx date 2025-10-08 		$FRX
Fennec Pharmaceuticals Inc. 		Southpoint Capital Advisors LP
3 - 10% Security Holder of Issuer
Holder: Southpoint Master Fund LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-185,663.271
-19,605 vol
$9.47 each 		4,030,709
Filed 2025-10-10 12:08
Tx date 2025-10-07 		$FRX
Fennec Pharmaceuticals Inc. 		Southpoint Capital Advisors LP
3 - 10% Security Holder of Issuer
Holder: Southpoint Master Fund LP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-257,892.99
-26,900 vol
$9.59 each 		4,050,314
Filed 2025-10-02 08:59
Tx date 2025-10-01 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+5,208 vol 		2,693,318
Filed 2025-10-02 08:57
Tx date 2025-10-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,430 vol 		225,590
Filed 2025-09-16 10:06
Tx date 2025-09-11 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$88,707
+36,207 vol
$2.45 each 		2,688,110
Filed 2025-09-16 10:05
Tx date 2025-09-11 		$FRX
Fennec Pharmaceuticals Inc. 		Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-88,707.15
-36,207 vol
$2.45 each 		21,487,456